alexa Psoriasis|omicsgroup|Journal Of Aging Science

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Psoriasis

Journal of Aging Science is one of the top leading journals in biomedical engineering which publishes novel research articles after rigorous peer-review process by at least 2 expert reviewers of the associated fields. It mainly deals with aging, reproductive aging, aging skin, biomarkers of aging, cognitive-aging, dementia, frailty, healthy-aging, geriatrics. Biological treatment of psoriasis has been guided solely by the clinical picture and the presence of side effects. Part of clinical trials include drug related pharmacokinetics and immunogenicity. During the clinical trials the formation of antibodies to biologicals was detected. However, antibodies or drug levels are not examined in common practice. Andrea Kovacikova Curkova, Management of Infliximab Treated Patients with Psoriasis Based On Infliximab Plasma Levels and Antibodies to Infliximab. OMICS is devoted to the prompt publication of original findings of the highest scientific priority and value that provide novel mechanistic insights, represent a clear advance over previous Studies and have the potential to generate exciting future research.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on June, 2014

Top